Diyar Saeed

Diyar Saeed


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2014 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
DSDiyar Saeed
Diyar Saeed
HSHanna Stosik
Hanna Stosik
MIMerima Islamovic
Merima Islamovic
AAAlexander Albert
Alexander Albert
HKHiroyuki Kamiya
Hiroyuki Kamiya
ALArtur Lichtenberg
Artur Lichtenberg

1 March 2015 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
DSDiyar Saeed
Diyar Saeed
BMBujar Maxhera
Bujar Maxhera
HKHiroyuki Kamiya
Hiroyuki Kamiya
ALArtur Lichtenberg
Artur Lichtenberg
AAAlexander Albert
Alexander Albert

18 March 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CJChristian Jung
Christian Jung
SBSandra Bueter
Sandra Bueter
Bernhard WernlyBernhard Wernly
Bernhard Wernly
MMMaryna Masyuk
Maryna Masyuk
DSDiyar Saeed
Diyar Saeed
RWRalf Westenfeld
Ralf Westenfeld
Background: We evaluated critically ill patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR) due to cardiac arrest (CA) with respect to baseline characteristics and laboratory assessments, including lactate and lactate clearance for prognostic relevance. Methods: The primary endpoint was 30-day mortality. The impact on 30-day mortality was assessed by uni- and multivariable Cox regression analyses. Neurological outcome assessed by Glasgow Outcome Scale (GOS) was pooled into two groups: scores of 1–3 (bad GOS score) and scores of 4–5 (good GOS score). Results: A total of 93 patients were included in the study. Serum lactate concentration (hazard ratio (HR) 1.09; 95% confidence interval (CI) 1.04–1.13; p < 0.001), hemoglobin, (Hb; HR 0.87; 95% CI 0.79–0.96; p = 0.004), and catecholamine use were associated with 30-day-mortality. In a multivariable model, only lactate clearance (after 6 h; OR 0.97; 95% CI 0.94–0.997; p = 0.03) was associated with a good GOS score. The optimal cut-off of lactate clearance at 6 h for the prediction of a bad GOS score was at ≤13%. Patients with a lactate clearance at 6 h ≤13% evidenced higher rates of bad GOS scores (97% vs. 73%; p = 0.01). Conclusions: Whereas lactate clearance does not predict mortality, it was the sole predictor of good neurological outcomes and might therefore guide clinicians when to stop ECPR.

18 March 2016 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
DSDiyar Saeed
Diyar Saeed
BMBujar Maxhera
Bujar Maxhera
AAAlexander Albert
Alexander Albert
RWRalf Westenfeld
Ralf Westenfeld
THTill Hoffmann
Till Hoffmann
ALArtur Lichtenberg
Artur Lichtenberg
Left ventricular assist device (LVAD) pump thrombosis is one of the devastating complications following mechanical circulatory support implantation. Surgical pump exchange is a known high-risk surgery with a high perioperative mortality rate. We aim to summarize our experience with several other alternative approaches in patients with suspected HeartWare HVAD (HeartWare, Framingham, MA, USA) pump thrombosis. The outcome of HeartWare HVAD implantations performed at single institution from January 2010 to September 2015 was studied. Inclusion criteria were patients with suspected HeartWare HVAD pump thrombosis. Patients’ preoperative characteristics and outcome following various interventions were reviewed. A total of 94 HeartWare HVAD pumps were implanted in 91 patients. The inclusion criteria were met by 13 patients (14%) with a mean age of 55 ± 14 years old and a median total pump support duration of 467 days (11–937 days). A conservative approach using systemic thrombolysis (recombinant tissue plasminogen activator) + heparin was used in the majority of the patients (15 events = 65%). Heart transplantation was performed in 4 patients and device explantation in 2 patients. Other approaches were used in the rest of patients. Considering thrombolysis-related complications, 1 patient required resternotomy for bleeding after thrombolysis, which was necessary a few days after LVAD implant surgery and 2 patients developed minor intracranial bleeding after thrombolysis. One-year survival after the latest intervention was 69%. This report showed the feasibility of several alternative conservative approaches combining medications, minimally invasive and interventional methods for patients with HeartWare pump thrombosis. The outcome may be better than immediate surgical pump exchange.

1 June 2013 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
DSDiyar Saeed
Diyar Saeed
AAAlexander Albert
Alexander Albert
RWRalf Westenfeld
Ralf Westenfeld
BMBujar Maxhera
Bujar Maxhera
HGHildegard Gramsch-Zabel
Hildegard Gramsch-Zabel
JWJoachim Winter
Joachim Winter

19 September 2014 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
BMBujar Maxhera
Bujar Maxhera
AAAlexander Albert
Alexander Albert
EAEdward Ansari
Edward Ansari
EGErhard Godehardt
Erhard Godehardt
ALArtur Lichtenberg
Artur Lichtenberg
DSDiyar Saeed
Diyar Saeed